8-K
Current Report
LIFECORE BIOMEDICAL, INC. \DE\ Filed Acc 0001628280-20-000013
Results of operations · Exit or restructuring costs · Executive or director change
- Item 2.02 Results of operations and financial condition
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading lndc-20191124x8k.htm…